Life Sciences: AI-powered tissue analysis for drug development

Our life sciences offerings

Foundation
model licensing

Atlas 2 is the industry-leading image-based pathology foundation model; it is now available for life sciences companies to license.

Learn more

Pre-computed validation datasets

HETA readouts for TCGA and PanCAN's SPARK, gold-standard, multimodal datasets for developing and validating hypotheses.

Learn more

HETA (H&E
Tissue Application)

Our core H&E analysis platform, delivering comprehensive spatial readouts with the accuracy of expert pathologists.

Learn more

Biomarker and
target solutions

Custom biomarker models for proprietary biomarkers, and target and biomarker identification from multimodal data.

Learn more

From research to companion diagnostics

01
Today · RUO

Discover the signal

Profile archival tissue and identify spatial features that can act as biomarkers.

02
RUO to IUO

Qualify it in a trial

Use H&E-based biomarkers to stratify trial cohorts or predict therapy response.

03
Today · RUO

Deploy as a diagnostic

Take the biomarker into the clinic as a companion diagnostic, read from routine H&E with no extra stains or tissue.

Stay in the loop

Fill out the form to subscribe to our company newsletter, a periodic look at what we're building, who we're working with, and how teams are putting AI-powered pathology to work.

Fill out the form

Advance your drug development pipeline with machine learning